Several recent studies have reported that PARP-1 could negatively regulate bone resorption and that PARP inhibition could suppress the osteogenic differentiation of osteosarcoma cells and mouse mesenchymal stem cells18,19. The gene discussed is PARP1; the disease is osteosarcoma.